Alex Thompson

Q: What is Alex Thompson's success rate?

Alex Thompson currently has a success rate of 83.80210508523653.

Q: What is the average return of Alex Thompson's calls?

Their stock ratings have generated an average return of 73.68353605033195.

Stifel | Healthcare

Alex Thompson is an analyst from Stifel specializing in the Healthcare sector. Ranked #174 out of 4771 analysts, they have issued 13 stock ratings with a success rate of 83.80% and an average return of 73.68%.

With 13 ratings to date, Alex Thompson is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 83.80% and an average return of 73.68%, highlighting promising potential as their track record develops further.

#174

Out of 4771

Total Ratings

+83.80%

Success Rate

+73.68%

Average Return

Recent Ratings Analysis

SYRE

Buy

May 06, 2026

Target

$107.00

Current

$88.71

Performance

21.52%

Alex Thompson rated SYRE as Buy on May 06, 2026, setting a price target of 107. The call has proven timely, with shares rising 21.52% toward the price target of 107.

ORKA

Buy

Mar 13, 2026

Target

$72.00

Current

$91.65

Performance

129.13%

On Mar 13, 2026, ORKA was given a Buy rating by Alex Thompson, with a target price of 72. The stock rallied 129.13% after the rating, narrowing the gap to the target of 72 and validating the bullish stance.

ANAB

Buy

Mar 05, 2026

Target

$85.00

Current

$55.16

Performance

—

ANAB received a Buy rating from Alex Thompson on Mar 05, 2026, aiming for 85. Price action was muted, as shares hovered around 55.16 despite the bullish outlook.

CLDX

Buy

Feb 26, 2026

Target

$68.00

Current

$38.10

Performance

24.35%

On Feb 26, 2026, Alex Thompson published a Buy outlook on CLDX, with a target of 68. Shares gained 24.35%, underscoring the accuracy of the bullish outlook toward 68.

ALMS

Buy

Feb 25, 2026

Target

$44.00

Current

$9.90

Performance

-66.32%

Alex Thompson on Feb 25, 2026 assigned ALMS a Buy rating, with a price target of 44. The call has struggled to gain traction, with shares losing 66.32%.

PALI

Buy

Feb 25, 2026

Target

$5.00

Current

$2.01

Performance

5.79%

On Feb 25, 2026, Alex Thompson reaffirmed PALI with a Buy rating, targeting 5. The recommendation was supported by strong follow-through as the stock rose from 2.01 to 2.01.

ASND

Buy

Dec 11, 2025

Target

$256.00

Current

$261.23

Performance

24.30%

ASND was rated Buy by Alex Thompson on Dec 11, 2025, with a price objective of 256. A bullish response from the market helped close the gap of -5.23 to the target.

ARGX

Buy

Dec 11, 2025

Target

$1250.00

Current

$984.04

Performance

10.63%

On Dec 11, 2025, Alex Thompson initiated coverage on ARGX with a Buy rating and target of 1250. The stock’s climb of 10.63% since the call highlights the foresight in the rating.

TVTX

Hold

Sep 12, 2025

Target

$25.00

Current

$67.51

Performance

187.64%

Alex Thompson issued a Hold recommendation for TVTX on Sep 12, 2025, price target set at 25. A neutral call gave way to stronger-than-expected performance, closing in on 25.

DNTH

Buy

Sep 12, 2025

Target

$65.00

Current

$103.28

Performance

177.93%

On Sep 12, 2025, DNTH was evaluated by Alex Thompson, who gave a Buy rating and target of 65. This case illustrates how a timely bullish rating can translate into tangible gains of 177.93%.

THRD

Hold

Mar 28, 2025

Target

$5.00

Current

$5.38

Performance

53.28%

Alex Thompson rated THRD as Hold on Mar 28, 2025, setting a price target of 5. Despite the Hold call, shares climbed 53.28% to 5.38, revealing unexpected momentum.

CRNX

Buy

Mar 25, 2025

Target

$60.00

Current

$84.95

Performance

142.23%

On Mar 25, 2025, CRNX was given a Buy rating by Alex Thompson, with a target price of 60. The stock rallied 142.23% after the rating, narrowing the gap to the target of 60 and validating the bullish stance.

AVTX

Buy

Mar 25, 2025

Target

$36.00

Current

$17.18

Performance

101.17%

AVTX received a Buy rating from Alex Thompson on Mar 25, 2025, aiming for 36. Momentum has favored the Buy call, with shares climbing from 17.18 to 17.18, rewarding those who trusted the recommendation.

MORF

Hold

Jul 22, 2024

Target

$57.00

Current

$56.99

Performance

0.71%

On Jul 22, 2024, Alex Thompson published a Hold outlook on MORF, with a target of 57. Sideways action left the Hold view intact, with no major move since 56.99.

Frequency Asked Questions

Who is Alex Thompson?

Alex Thompson is an analyst from Stifel specializing in the Healthcare sector.

What is Alex Thompson's success rate?

Alex Thompson currently has a success rate of +83.80%.

How many ratings has Alex Thompson issued?

Alex Thompson has issued 13 stock ratings so far.

What is the average return of Alex Thompson's calls?

Their stock ratings have generated an average return of +73.68%.

What is Alex Thompson's ranking?

Alex Thompson is ranked #174 out of 4771 analysts.

What types of ratings does Alex Thompson give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Alex Thompson?

You can follow Alex Thompson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Alex Thompson?

Their latest rating was a Buy on SYRE issued on 2026-05-06.